紫术消瘤散对持续性HPV感染患者阴道微生态的影响
Effect of Zishu Xiaoliu Powder on Vaginal Microecology in Patients with Persistent HPV Infection
DOI: 10.12677/jcpm.2024.34356, PDF,    科研立项经费支持
作者: 陈秋燕, 吴冬梅*, 林丽君, 刘 倩:福建中医药大学附属第二人民医院,福建 福州
关键词: 紫术消瘤散宫颈高危型人乳头瘤病毒Zishu Xiaoliu Powder HR-HPV
摘要: 目的:研究紫术消瘤散对宫颈高危型人乳头瘤病毒(HR-HPV)持续感染湿热瘀结型患者阴道菌群的调控作用,探讨紫术消瘤散清除人乳头瘤病毒的作用机制。方法:通过随机对照的临床试验研究,选取来源于福建省第二人民医院妇科门诊及体检中心,符合间隔12个月或以上,连续两次同一亚型HR-HPV检测为阳性者,且严格遵循三阶梯(HPV + TCT–阴道镜检查–宫颈活检)的诊疗规范,经由宫颈活检病理明确诊断为 ≤ LSIL,中医辨证为湿热瘀结型的患者64例,按随机数字表法分为治疗组和对照组。每组32例。治疗组:紫术消瘤散宫颈局部上药,每3天1次,1次4 g,1个月1个疗程,连续使用3个疗程。对照组:予阴道用乳杆菌活菌胶囊,每晚睡前清洗外阴后塞入阴道深部,10天为1个疗程,连续用药3个疗程。观察两组治疗前后患者HPV转阴率、中医证候积分、阴道微生态指标(菌群密集度、菌群多样性、优势菌、pH、Nugent评分)的变化。结果:① 治疗组HR-HPV转阴率(65.6%)比对照组(37.5%)高,差异有统计学意义(P < 0.05)。② 两组经治疗后中医症候积分均较治疗前下降,治疗组积分下降情况较对照组更为显著,结果均有统计学意义(P < 0.05)。③ 两组治疗后菌群密集度、菌群多样性、优势菌、Nugent评分较治疗前均明显改善,差异有统计学意义(P < 0.05)。结论:紫术消瘤散、阴道用乳杆菌活菌胶囊均能够在一定程度恢复阴道微生态平衡、逆转HR-HPV感染,值得临床推广。
Abstract: Objective: To study the regulatory effect of Zishu Xiaoliu Powder on vaginal flora in patients with persistent cervical high-risk human papillomavirus (HR-HPV) infection of damp-heat stasis type, and to explore the mechanism of action of Zishu Xiaoliu Powder in clearing human papillomavirus. Methods: Through a randomized controlled clinical trial, patients from the gynecological outpatient clinic and physical examination center of the Second People’s Hospital of Fujian Province who were positive for the same subtype of HR-HPV for two consecutive times with an interval of 12 months or more and strictly followed the three-step (HPV + TCT-colposcopy-cervical biopsy) diagnosis and treatment standards were selected. 64 patients were diagnosed as ≤LSIL by cervical biopsy pathology and damp-heat stasis type by TCM syndrome differentiation. They were divided into treatment group and control group according to the random number table method. 32 cases in each group. Treatment group: Zishu Xiaoliu Powder was applied topically to the cervix, once every 3 days, 4g each time, 1 month as a course of treatment, and 3 courses of treatment were used continuously. Control group: Lactobacillus capsules were used for vaginal use, and the capsules were inserted deep into the vagina after cleaning the vulva every night before going to bed. 10 days was a course of treatment, and 3 courses of treatment were used continuously. The changes in the HPV negative conversion rate, TCM syndrome scores, and vaginal microecological indicators (bacterial density, bacterial diversity, dominant bacteria, pH, and Nugent score) of the two groups of patients before and after treatment were observed. Results: ① The HR-HPV negative conversion rate in the treatment group (65.6%) was higher than that in the control group (37.5%), and the difference was statistically significant (P < 0.05). ② After treatment, the TCM symptom scores of both groups decreased compared with those before treatment, and the score decrease in the treatment group was more significant than that in the control group, and the results were statistically significant (P < 0.05). ③ After treatment, the density, diversity, dominant bacteria, and Nugent scores of the two groups were significantly improved compared with those before treatment, and the differences were statistically significant (P < 0.05). Conclusion: Zishu Xiaoliu Powder and Vaginal Lactobacillus Live Capsules can restore the balance of vaginal microecology and reverse HR-HPV infection to a certain extent, and are worthy of clinical promotion.
文章引用:陈秋燕, 吴冬梅, 林丽君, 刘倩. 紫术消瘤散对持续性HPV感染患者阴道微生态的影响[J]. 临床个性化医学, 2024, 3(4): 2498-2504. https://doi.org/10.12677/jcpm.2024.34356

参考文献

[1] 高燕. 高危型人乳头状瘤病毒持续感染与宫颈癌前病变关系的研究进展[J]. 抗感染药学, 2022, 19(5): 626-629.
[2] 任玮琦. 宫颈高危型人乳头瘤病毒感染与局部免疫和阴道菌群分布的关系[J]. 中国妇幼保健, 2022, 37(21): 3914-3918.
[3] 侯月敏, 安瑞芳. 阴道内环境与HPV感染[J]. 实用妇产科杂志, 2021, 37(12): 887-889.
[4] 詹炳南. 谢德聪紫术消瘤散治疗湿热瘀结型宫颈HR-HPV持续感染的疗效观察[D]: [硕士学位论文]. 福州: 福建中医药大学, 2020.
[5] 刘倩, 刘用诚, 詹炳南, 等. 紫术消瘤散对不同类型宫颈HR-HPV持续感染的临床疗效分析[J]. 中医药息, 2023, 40(3): 62-66.
[6] 陈秋燕, 吴冬梅, 杨青青. 紫术消瘤散对P16/Ki67在子宫颈低级别鳞状上皮内瘤变表达的影响[J]. 医学诊断, 2022, 12(2): 180-185.
[7] 谢幸, 孔北华, 段涛, 等. 妇产科学[M]. 第9版. 北京: 人民卫生出版社, 2018: 295-297.
[8] 冯晓玲, 张婷婷. 中医妇科学[M]. 第5版. 北京: 中国中医药出版社, 2021: 135-143.
[9] Chen, Y., Qiu, X., Wang, W., Li, D., Wu, A., Hong, Z., et al. (2020) Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Progression Are Associated with Increased Vaginal Microbiome Diversity in a Chinese Cohort. BMC Infectious Diseases, 20, Article No. 629. [Google Scholar] [CrossRef] [PubMed]
[10] Braundmeier, A.G., Lenz, K.M., Inman, K.S., Chia, N., Jeraldo, P., et al. (2015) Individualized Medicine and the Microbiome in Reproductive Tract. Frontiers in Physiology, 6, Article No. 97. [Google Scholar] [CrossRef] [PubMed]
[11] 陈炎. 抗HPV蛋白敷料治疗HPV感染合并CINI期的疗效观察[J]. 成都医学院学报, 2016, 11(3): 327-329.
[12] 廖秦平, 刘朝晖, 薛凤霞, 等. 阴道用乳杆菌活菌胶囊临床应用中国专家共识(2023年版) [J]. 中国实用妇科与产科杂志, 2023, 39(5): 537-546.
[13] 辛晓玲, 刘志杰, 蒋汉霞. 苦参对高危型HPV感染的CIN1患者宫颈局部T细胞亚群的影响[J]. 环球中医药, 2015, 8(S2): 150.
[14] Pei, Z., Zeng, J., Gao, Y., Li, F., Li, W., Zhou, H., et al. (2016) Oxymatrine Inhibits the Proliferation of Caski Cells via Downregulating HPV16E7 Expression. Oncology Reports, 36, 291-298. [Google Scholar] [CrossRef] [PubMed]
[15] 周扬. 白芨治疗高危型HPV感染合并CINI级的临床观察[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2015: 25-34.